Société Eidos Therapeutics, Inc.
Actions
EIDX
US28249H1041
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 01/03/16 |
Jonathan Fox
PSD | President | 66 | 01/10/16 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/21 |
Jonathan Fox
PSD | President | 66 | 01/10/16 |
Neil Kumar
CEO | Chief Executive Officer | 45 | 01/03/16 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 38 872 893 | 12 835 887 ( 33,02 %) | 0 | 33,02 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+3,91% | 109 Md | |
+10,87% | 105 Md | |
+1,28% | 22,25 Md | |
-13,14% | 22,09 Md | |
-7,05% | 18,68 Md | |
-38,36% | 17,58 Md | |
-10,66% | 16,85 Md | |
+3,75% | 13,76 Md | |
+36,70% | 12,46 Md |